Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.

被引：0
|
作者：
Harker, LA
Marzec, UM
Novembre, F
Sundell, IB
Waller, EK
Karpatkin, S
McClure, HM
Kelly, AB
Stead, RB
机构：
[1] EMORY UNIV,ATLANTA,GA 30322
[2] NYU,MED CTR,NEW YORK,NY 10016
[3] AMGEN INC,THOUSAND OAKS,CA 91320
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：754 / 754
页数：1
相关论文
共 50 条
  • [21] Effects of recombinant human megakaryocyte growth and development factor on platelet activation
    Montrucchio, G
    Brizzi, MF
    Calosso, G
    Marengo, S
    Pegoraro, L
    Camussi, G
    BLOOD, 1996, 87 (07) : 2762 - 2768
  • [22] Pegylated recombinant human megakaryocyte growth and development factor synergizes with recombinant human granulocyte colony stimulating factor to expand hematopoietic stem cells in vivo in mice.
    Akahori, H
    Tawara, T
    Sawa, Y
    Ida, M
    Ozai, M
    Kato, T
    Miyazaki, H
    BLOOD, 1998, 92 (10) : 111A - 111A
  • [23] Decreased prothrombotic effects of pegylated recombinant human megakaryocyte growth and development factor in thrombocytopenic state in a rat thrombosis model
    Nishiyama, U
    Kuwaki, T
    Akahori, H
    Kato, T
    Ikeda, Y
    Miyazaki, H
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (02) : 355 - 360
  • [24] Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer
    Basser, RL
    Rasko, JEJ
    Clarke, K
    Cebon, J
    Green, MD
    Hussein, S
    Alt, C
    Menchaca, D
    Tomita, D
    Marty, J
    Fox, RM
    Begley, CG
    LANCET, 1996, 348 (9037): : 1279 - 1281
  • [25] Pegylated recombinant human megakaryocyte growth and development factor stimulates mobilization of hematopoietic progenitor cells into the peripheral blood in mice
    Torii, Y
    Nitta, Y
    Ida, M
    Kuwaki, T
    Akahori, H
    Kato, T
    Miyazaki, H
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 288 - 288
  • [26] IMMUNOGENICITY OF RECOMBINANT HUMAN ADENOVIRUS HUMAN-IMMUNODEFICIENCY-VIRUS VACCINES IN CHIMPANZEES
    NATUK, RJ
    LUBECK, MD
    CHANDA, PK
    CHENGALVALA, M
    WADE, MS
    MURTHY, SCS
    WILHELM, J
    VERNON, SK
    DHEER, SK
    MIZUTANI, S
    LEE, SG
    MURTHY, KK
    EICHBERG, JW
    DAVIS, AR
    HUNG, PP
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (05) : 395 - 404
  • [27] In vitro effects of recombinant human megakaryocyte growth and development factor on primary human tumour colony growth
    Lang, SH
    West, CML
    Jones, L
    Brooks, B
    Kasper, C
    deWynter, E
    Testa, NG
    ONCOLOGY, 1997, 54 (02) : 141 - 145
  • [28] PEGylated recombinant human megakaryocyte growth and development factor effectively improves thrombocytopenia a murine model of idiopathic thrombocytopenic purpura, (NZW x BXSB)F1.
    Shibuya, K
    Akahori, H
    Tahara, E
    Kato, T
    Miyazaki, H
    BLOOD, 1998, 92 (10) : 376A - 377A
  • [29] Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression
    Coleman, D
    Fairchild, D
    Schindler-Horvat, J
    Munyakazi, L
    Neumann, TAK
    TOXICOLOGICAL SCIENCES, 1998, 45 (01) : 77 - 87
  • [30] Dapsone therapy for thrombocytopenia in patients infected with human immunodeficiency virus
    Durand, JM
    Lefevre, P
    Cretel, E
    Kaplanski, G
    Soubeyrand, J
    CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) : 1131 - 1131
12345